Liquid Biopsy Predicts Response in Patients with Advanced Lung Cancer

Liquid Biopsy Predicts Response in Patients with Advanced Lung Cancer

Johns Hopkins researchers are pioneering the use of a “liquid biopsy” to predict which patients with advanced lung cancers are responding to immunotherapies and which patients may develop immune-related side effects several months later.

 READ HERE
SEE ALL NEWS
Recent Posts
Podcast: Colorectal Cancer Why age matters when it comes to cancer Experimental Drug Combination Shows Promise Against Hard-to-Treat Tumors What are the risk factors for Pancreatic Cancer? New Lung Tumor Scoring System Prostate Cancer: Advancements in Screenings 5 Healthy Habits That Help You During Lung Cancer Treatment Six Mammogram Myths Active Care Model Predicts Disease Course for Prostate Cancers